東方盛虹(000301.SZ):控股股東及其關聯企業的部分員工擬增持公司5億-8.45億元股份
格隆匯3月23日丨東方盛虹(000301.SZ)公佈,公司於2020年3月23日接到公司控股股東江蘇盛虹科技股份有限公司(“盛虹科技”)的通知,盛虹科技及其關聯企業(除上市公司及上市公司控股子公司外)的部分員工擬委託金融機構成立專項集合資金信託計劃(“集合資金信託”)通過二級市場購買等方式增持公司股份。
此次增持擬由盛虹科技或其關聯企業選定的金融機構專項設立集合資金信託,預計總規模在5億元至8.45億元之間,擬持有上市公司股票總數累計不超過上市公司股本總額的5%;單個員工所獲股份權益對應的股票總數累計不超過上市公司股本總額的1%。具體認購規模將根據參與者的認購情況而定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.